Compositions and methods for the transport of therapeutic agents
AssigneeAngiochem Inc.
InventorsJean-Paul CASTAIGNE, Michel Demeule, Christian Che, Anthony Regina
Life of this patent
Estimating the term…
Abstract
The present invention is directed to conjugates that include a polypeptide capable of crossing the blood-brain barrier or entering one or more cell types attached to a transport vector, i.e., a composition capable of transporting an agent (e.g., a therapeutic agent). In certain cases, the polypeptides are directly conjugated to a lipid or polymeric vector to allow targeted application of a therapeutic agent to treat, for example, a cancer, a neurodegenerative disease, or a lysosomal storage disorder.
Claims30
A compound comprising a polypeptide and a transport vector, wherein:
- (A) said polypeptide:
- (a) comprises an amino acid sequence having at least 70% sequence identity to the sequence of SEQ ID NO:97 or to any of the sequences set forth in SEQ ID NOS:1-93, 98-105, and 107-116;
- and
- (b) is conjugated to said transport vector, or
- (B) said compound comprises the formula:
- A-X-B, wherein:
- (a) A is a polypeptide comprising an amino acid sequence having at least 70% sequence identity to the sequence of Angiopep-2 (SEQ ID NO:97) or of SEQ ID NOS:1-93, 98-105, and 107-116;
- (b) X is a linker;
- and
- (c) B is a transport vector.
Dependencies are inferred from the claim text.